Omnipaque 140

See also: Generic Omnipaque 180, Generic Omnipaque 240, Generic Omnipaque 300, Generic Omnipaque 350

Omnipaque 140 is a brand name of iohexol, approved by the FDA in the following formulation(s):

OMNIPAQUE 140 (iohexol - injectable; injection)

• 
  Manufacturer: GE HEALTHCARE
  
  Approval date: November 30, 1988
  
  Strength(s): 30.2% ^[RLD]

Has a generic version of Omnipaque 140 been approved?

No. There is currently no therapeutically equivalent version of Omnipaque 140 available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omnipaque 140. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Omnipaque 140.

See also...